65 related articles for article (PubMed ID: 23235757)
1. Long-term outcomes of concomitant chemoradiotherapy incorporating high-dose-rate brachytherapy to treat locally advanced cervical cancer.
Lee HJ; Kim YS; Shin SS; Nam JH; Kim YT; Han S; Choi EK
Tumori; 2012; 98(5):615-21. PubMed ID: 23235757
[TBL] [Abstract][Full Text] [Related]
2. A Comparative Study of Clinical Outcomes in Locally Advanced Cervical Cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A Tertiary Care Center Randomized Controlled Trial in India.
Alim S; Siddiqui SA; Akram M; Hakim S; Khan MA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1333-1338. PubMed ID: 38679994
[TBL] [Abstract][Full Text] [Related]
3. Locally advanced cervical cancer: how the improvement in techniques in external beam radiotherapy and brachytherapy impacts on survival outcomes and long-term toxicities.
Barbera F; Frassine F; Volpi G; Ghedi B; Pasinetti N
Radiol Med; 2023 Dec; 128(12):1542-1552. PubMed ID: 37640897
[TBL] [Abstract][Full Text] [Related]
4. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC;
Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207
[TBL] [Abstract][Full Text] [Related]
5. Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone.
Mabuchi S; Ugaki H; Isohashi F; Yoshioka Y; Temma K; Yada-Hashimoto N; Takeda T; Yamamoto T; Yoshino K; Nakajima R; Kuragaki C; Morishige K; Enomoto T; Inoue T; Kimura T
Gynecol Obstet Invest; 2010; 69(4):224-232. PubMed ID: 20068328
[TBL] [Abstract][Full Text] [Related]
6. Results of Definitive (Chemo)radiotherapy Using Computed Tomography-based Brachytherapy for Cervical Cancer.
Aoshika T; Noda SE; Abe T; Kumazaki YU; Hirai R; Igari M; Saito S; Ryuno Y; Iino M; Takeda Y; Ohta T; Watanabe J; Tsukahara K; Kato S
Anticancer Res; 2024 Apr; 44(4):1583-1589. PubMed ID: 38537975
[TBL] [Abstract][Full Text] [Related]
7. Can Chemotherapy be Integrated with Brachytherapy in Locally Advanced Carcinoma Cervix- A Proof of Principle Study.
Gupta S; Giridhar P; Sharma D; K P H; P K J; Rath GK
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2653-2657. PubMed ID: 31554360
[TBL] [Abstract][Full Text] [Related]
8. From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience.
Espenel S; Garcia MA; Trone JC; Guillaume E; Harris A; Rehailia-Blanchard A; He MY; Ouni S; Vallard A; Rancoule C; Ben Mrad M; Chauleur C; De Laroche G; Guy JB; Moreno-Acosta P; Magné N
Radiat Oncol; 2018 Feb; 13(1):16. PubMed ID: 29394940
[TBL] [Abstract][Full Text] [Related]
9. Phase 2 Randomized Controlled Trial of Radiation Therapy Plus Concurrent Interferon-Alpha and Retinoic Acid Versus Cisplatin for Stage III Cervical Carcinoma.
Basu P; Jenson AB; Majhi T; Choudhury P; Mandal R; Banerjee D; Biswas J; Pan J; Rai SN; Ghim SJ; Miller D
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):102-110. PubMed ID: 26700705
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study.
Ariga T; Toita T; Kato S; Kazumoto T; Kubozono M; Tokumaru S; Eto H; Nishimura T; Niibe Y; Nakata K; Kaneyasu Y; Nonoshita T; Uno T; Ohno T; Iwata H; Harima Y; Wada H; Yoshida K; Gomi H; Numasaki H; Teshima T; Yamada S; Nakano T
J Radiat Res; 2015 Sep; 56(5):841-8. PubMed ID: 26109680
[TBL] [Abstract][Full Text] [Related]
11. Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomotherapy.
Hsieh CH; Wei MC; Lee HY; Hsiao SM; Chen CA; Wang LY; Hsieh YP; Tsai TH; Chen YJ; Shueng PW
Radiat Oncol; 2009 Dec; 4():62. PubMed ID: 20003321
[TBL] [Abstract][Full Text] [Related]
12. Monocentric Retrospective Study: Efficacy, Feasibility, and Prognostic Factors of Single-Insertion High-Dose-Rate Brachytherapy With 4 Sessions for Locally Advanced Cervical Cancer.
Houdou L; Meynard C; Guillerm S; Mimoun C; Lambert T; Marchand E; Jornet D; Fumagalli I; Quero L; Huchon C; Hennequin C
Adv Radiat Oncol; 2024 Jul; 9(7):101512. PubMed ID: 38883995
[TBL] [Abstract][Full Text] [Related]
13. Online Adaptive Magnetic Resonance-guided Radiation Therapy for Gynaecological Cancers: Preliminary Results of Feasibility and Outcome.
Ugurluer G; Zoto Mustafayev T; Gungor G; Abacioglu U; Atalar B; Ozyar E
Clin Oncol (R Coll Radiol); 2024 Jan; 36(1):12-20. PubMed ID: 38016848
[TBL] [Abstract][Full Text] [Related]
14. A comparative study between two different dose fractionation schedules of cobalt-60-based HDR intracavitary brachytherapy in carcinoma cervix stages IIB-IIIC1.
Gagrani V; Kabara J; Shukla A; Rathore NK; Rajpurohit VS; Jangid PK; Manna S
J Cancer Res Ther; 2024 Jan; ():. PubMed ID: 38261446
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Image-Guided Intensity-Modulated Radiation Therapy and Volumetric Modulated Arc Therapy Combined with Paclitaxel Liposomes and Cisplatin for Locally Advanced Stage IIB-IIIB Cervical Cancer: A Retrospective Study at a Single Center.
Xie M; Ding X; Chen A; Xiao H; Wang X; Wang Y; Zhang H
Med Sci Monit; 2020 Dec; 26():e927563. PubMed ID: 33293504
[TBL] [Abstract][Full Text] [Related]
16. Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres.
Hoskin P; Lee M; Dunkley D; Danh M; Wickens R; Saunders G; Northey J; Crabb S; McFarlane V; Sadozye A; Cooper R; Mathew T; Haslett K; Reeves K; Reed R; Bigos K; Williams KJ; Rowling E; Choudhury A; Dancer S; Smith D; Griffiths G
BMC Cancer; 2024 Jun; 24(1):702. PubMed ID: 38849715
[TBL] [Abstract][Full Text] [Related]
17. Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers.
Kunos CA; Radivoyevitch T; Waggoner S; Debernardo R; Zanotti K; Resnick K; Fusco N; Adams R; Redline R; Faulhaber P; Dowlati A
Gynecol Oncol; 2013 Jul; 130(1):75-80. PubMed ID: 23603372
[TBL] [Abstract][Full Text] [Related]
18. Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan Africa.
Lin LL; Ndlovu N; Lowenstein J; Wirth M; Lee J; Stier EA; Garg M; Kotzen J; Kadzatsa W; Palefsky J; Krown SE; Einstein MH
Int J Radiat Oncol Biol Phys; 2023 Jun; 116(2):439-447. PubMed ID: 36493958
[TBL] [Abstract][Full Text] [Related]
19. A study of high-dose-rate intracavitary brachytherapy boost for curative treatment of uterine cervical cancer.
Okuma K; Yamashita H; Kobayashi R; Nakagawa K
J Contemp Brachytherapy; 2015 Apr; 7(2):128-34. PubMed ID: 26034493
[TBL] [Abstract][Full Text] [Related]
20. Characteristics, treatment patterns, and outcomes in patients with high-risk locally advanced cervical cancer.
Coutinho F; Gokhale M; Doran C; Monberg M; Yamada K; Chen L
Cancer Treat Res Commun; 2024; 39():100800. PubMed ID: 38430610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
